Expression of the cell-cell adhesion molecule β-catenin in colorectal carcinomas and their metastases

APMIS

Volumn 116, Issue 1, 2008, Pages 1-9

  Buhmeida, A ^a   Elzagheid, A ^a,b   Algars A ^a   Collan, Y ^b   Syrjanen K ^a   Pyrhonen S ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

catenin expression; Primary and metastatic colorectal cancer

Indexed keywords

BETA CATENIN;

AGE; ARTICLE; ASCENDING COLON; CANCER GRADING; CANCER SURVIVAL; CELL ADHESION; COLORECTAL CARCINOMA; CYTOPLASMIC INDEX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE; MALE; METASTASIS; NUCLEAR INDEX; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SURVIVAL; WILCOXON SIGNED RANKS TEST;

BETA CATENIN; CELL ADHESION; CELL MEMBRANE; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 38849201199     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00754.x     Document Type: Article

References (36)

1. Gatta G, Faivre J, Capocaccia R, Ponz de Leon M. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998 34 : 2176 83.
2. Repetto L, Venturino A, Fratino L, Serraino D, Troisi G, Gianni W, et al. Geriatric oncology: a clinical approach to the older patient with cancer. Eur J Cancer 2003 39 : 870 80.
3. Wymenga AN, Slaets JP, Sleijfer DT. Treatment of cancer in old age, shortcomings and challenges. Neth J Med 2001 59 : 259 66.
4. Franceschi S, La Vecchia C. Cancer epidemiology in the elderly. Crit Rev Oncol Hematol 2001 39 : 219 26.
5. Donohue JH, Williams S, Cha S, Windschitl HE, Witzig TE, Nelson H, et al. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol 1995 13 : 1671 8.
6. Greenlee RT, Hill-Harmon MB, Murray T, Thun M : Cancer statistics. CA Cancer J Clin 2001 51 : 144.
7. Steele G Jr., Ravikumar TS, Benotti PN. Surgical treatments for recurrent colorectal cancer. Cancer 1990 65 : 723 30.
8. Bruckner HW, Motwani BT. Chemotherapy of advanced cancer of the colon and rectum. Semin Oncol 1991 18 : 443 61.
9. Elzagheid A, Algars A, Bendardaf R, Lamlum H, Ristamaki R, Collan Y, et al. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol 2006 21 : 4304 9.
10. Ozawa M, Kemler R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol 1992 116 : 989 96.
11. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998 12 : 190 3.
12. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997 275 : 1784 7.
13. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997 275 : 1787 90.
14. Birchmeier W, Weidner KM, Hulsken J, Behrens J. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 1993 4 : 231 9.
15. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 1999 80 : 1046 51.
16. Elzagheid A, Kuopio T, Ilmen M, Collan Y. Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology 2002 41 : 127 33.
17. Bendardaf R, Elzagheid A, Lamlum H, Ristamaki R, Collan Y, Pyrhonen S. E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer. Oncol Rep 2005 13 : 831 5.
18. Lipponen P, Collan Y. Simple quantitation of immuno-histochemical staining positivity in microscopy. Acta Stereol 1992 11 : 125 32.
19. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989 56 : 1057 62.
20. Khoursheed MA, Mathew TC, Makar RR, Louis S, Asfar SK, Al-Sayer HM, et al. Expression of E-cadherin in human colorectal cancer. Surgeon 2003 1 : 86 91.
21. Berx G, Nollet F, van Roy F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 1998 6 : 171 84.
22. Kirchner T, Brabletz T. Patterning and nuclear β-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol 2000 157 : 1113 21.
23. Barth AI, Nalhke IS, Nelson WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 1997 19 : 683 90.
24. Kirchner T, Brabletz T. Patterning and nuclear β-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol 2000 157 : 1113 21.
25. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998 194 : 701 4.
26. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 2004 15 : 1401 8.
27. Horkko TT, Klintrup K, Makinen JM, Napankangas JB, Tuominen HJ, Makela J, et al. Budding invasive margin and prognosis in colorectal cancer-no direct association with beta-catenin expression. Eur J Cancer 2006 42 : 964 71.
28. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ, et al. beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 1999 12 : 504 11.
29. Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y, et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000 59 : 302 9.
30. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumour location. Ann Intern Med 1990 15 : 779 88.
31. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994 28 : 213 21.
32. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994 106 : 42 8.
33. Han Q, Zhao W, Bentel J, Shearwood A, Zeps N, Joseph D, et al. Expression of sFRP-4 and β-catenin in human colorectal carcinoma. Cancer Lett 2006 231 : 129 37.
34. Green DW, Roh H, Pippin JA, Drebin JA. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. J Surg Res 2001 101 : 16 20.
35. Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y, et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000 59 : 302 9.
36. Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 2002 122 : 60 71.